COVID-19’s lasting impact on digital communication in healthcareThe ongoing digital transformation of the healthcare and pharmaceutical industries has been greatly accelerated during the coronavirus pandemic. Share XCOVID-19’s lasting impact on digital communication in healthcarehttps://pharmaphorum.com/whitepapers/covid-19s-lasting-impact-on-digital-communication-in-healthcare/
Coronavirus pharma news roundup – 31/07/20Vaccines, AI-driven drug discovery and llamas all hit the headlines this week as the search for a way Share XCoronavirus pharma news roundup – 31/07/20https://pharmaphorum.com/views-and-analysis/coronavirus-pharma-news-roundup-31-07-20/
Preparing for the next decade of innovation in immuno-oncologyImmuno-oncology has seen some striking clinical advances in the 10 years since the approval of the first therapeutic Share XPreparing for the next decade of innovation in immuno-oncologyhttps://pharmaphorum.com/oncology/immuno-oncology-clinicial-trial-market-access/
Livestream of digital health event Fight The PandemicThe global health ecosystem’s unified effort in fighting the unparalleled challenge presented by COVID-19 will be the subject Share XLivestream of digital health event Fight The Pandemichttps://pharmaphorum.com/views-and-analysis/digital-health-innovation-covid-event/
Homeschooling resources during coronavirus working-from-homeWith schools closed and many pharma and healthcare companies asking employees to work from home during the coronavirus Share XHomeschooling resources during coronavirus working-from-homehttps://pharmaphorum.com/views-analysis-sales-marketing/homeschooling-resources-coronavirus-covid19-working-home/
AI for rare diseases: putting tech to work for small populationsWith the 12th annual Rare Disease Day on the horizon, it’s a pertinent time to think about how Share XAI for rare diseases: putting tech to work for small populationshttps://pharmaphorum.com/spotlight/ai-in-pharma-marketing/ai-rare-diseases/
Nine for 2019: how did we do on our predictions, and what does this mean for 2020?Year-ends prompt reflection, both on what’s happened in the last 12 months and on the year ahead. At Share XNine for 2019: how did we do on our predictions, and what does this mean for 2020?https://pharmaphorum.com/views-and-analysis/nine-for-2019-2020/
Leading from the front in cell therapyIn these videos, senior stakeholders from Kite, a Gilead Company, describe how a culture of innovation and partnership Share XLeading from the front in cell therapyhttps://pharmaphorum.com/video/leading-from-the-front-in-cell-therapy/
How to craft responsive clinical trials that are designed for successWithout the right design, right data and right decisions, idealised clinical trial plans cannot be translated into blueprints Share XHow to craft responsive clinical trials that are designed for successhttps://pharmaphorum.com/r-d/how-to-craft-responsive-clinical-trials-that-are-designed-for-success/
